signaling pathway plays an important role in lower urinary tract, principally in the penis. Additionally, NO may contribute to the regulation of urethral and bladder smooth muscle tone. Sickle cell (SC) mouse model exhibit overactive bladder symptoms, but the mechanisms are not understood. We hypothesize that NO dysregulation causes overactive bladder, while NO-releasing nanoparticles (NO-NP), a novel NO delivery system, decreases detrusor overactivity, using eNOS-and nNOSdeficient (dNOS-/-) knockout and SC mice.
INTRODUCTION AND OBJECTIVES: Nitric oxide (NO)
signaling pathway plays an important role in lower urinary tract, principally in the penis. Additionally, NO may contribute to the regulation of urethral and bladder smooth muscle tone. Sickle cell (SC) mouse model exhibit overactive bladder symptoms, but the mechanisms are not understood. We hypothesize that NO dysregulation causes overactive bladder, while NO-releasing nanoparticles (NO-NP), a novel NO delivery system, decreases detrusor overactivity, using eNOS-and nNOSdeficient (dNOS-/-) knockout and SC mice.
METHODS: SC (n¼18) and dNOS-/-knockout (n¼22) mice were used as animal models of overactive bladder and compared to wild type (WT) (n¼15) mice. Empty-NP or NO-NP were injected into the bladder. After 10 minutes, cystometric studies were performed. For molecular studies, bladder tissues were collected from separate groups of mice; the expression levels of proteins that regulate detrusor relaxation (nitric oxide synthase pathway) or contraction (RhoA/Rho-kinase pathway) were assessed. For statistical analysis, the Student's t-test and one-way analysis of variance (ANOVA) were used.
RESULTS: SC and dNOS-/-mice had significantly higher (P < 0.05) voiding and non-voiding contraction frequencies and significantly lower (P < 0.05) compliance compared to WT mice. NO-releasing nanoparticles normalized these abnormalities in both SC and dNOS-/-mice. RhoA/Rho-kinase pathway, reflected by phosphorylation of myosin phosphatase target subunit 1 (P-MYPT-1), was increased (P < 0.05) in the bladder of SC mice compared to WT, which was reversed by NO-releasing nanoparticles. eNOS phosphorylation on positive (Ser-1177) regulatory site was decreased (P < 0.05) in the bladder of SC mice compared to WT, which was reversed by NO-releasing nanoparticles. nNOS phosphorylation on Ser-1412 and VASP phosphorylation on Ser-239 (a substrate of protein kinase G-I and a marker of the integrity of the NO/cGMP signaling pathway) were not different between SC and WT mouse bladders. Empty-NP did not affect any of the measured parameters.
CONCLUSIONS: Dysregulation of NO and RhoA/Rho-kinase pathways is associated with detrusor overactivity in SC mice; NOreleasing nanoparticles reverse these molecular derangements in the bladder and decrease detrusor overactivity.
Source of Funding: This study was supported by a grant from the National Health Institute (R01DK067223).
PD19-07 CRH NEURONS OF BARRINGTON'S NUCLEUS ARE NECESSARY BUT NOT SUFFICIENT FOR CO-ORDINATED VOIDING IN MICE
Hiroki Ito*, Marcus Drake, Christopher Fry, Bristol, United Kingdom; Anthony Kanai, Pittsburgh, PA; Anthony Pickering, Bristol, United Kingdom INTRODUCTION AND OBJECTIVES: The pontine micturition centre (PMC) is thought to activate the sacral parasympathetic neurons controlling the detrusor and inhibit the somatic motoneurons of the external urethral sphincter (EUS). Many PMC neurons express corticotropin-releasing hormone (CRH) and a recent study using CRH-ires-CRE knock-in mice enabled opto-and chemo-genetic manipulation of their activity (Hou et al. Cell 2016) . This indicated that the CRH neurons Vol. 199, No. 4S, Supplement, Saturday, May 19, 2018 THE JOURNAL OF UROLOGY â e397
